MDGL — MADRIGAL PHARMACEUTICALS, INC.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1157601 ·
Last close
$421.99
Market Cap
$9.80B
52W High
$615.00
52W Low
$353.54
ADV30
506,542
Next earnings
2026-11-03
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 431,268,000 | 393,453,000 | 55,989,000 | 55,442,000 | 1,434,389,000 | 514,642,000 | 807,448,000 |
| Jun 2026 | 364,252,000 | 324,245,000 | -56,308,000 | -57,939,000 | 1,244,645,000 | 292,726,000 | 720,921,000 |
| Mar 2026 | 311,337,000 | 284,490,000 | -92,723,000 | -94,391,000 | 1,227,327,000 | 227,033,000 | 683,873,000 |
| Dec 2025 | 321,083,000 | 296,635,000 | -59,609,000 | -58,575,000 | 1,259,589,000 | 198,693,000 | 656,900,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-157,010,000
Investing CF
$347,758,000
Financing CF
$24,362,000
CapEx
$-12,030,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-5.98
As of
2026-11-08
Balance + Analyst (yfinance extras)
Retained Earnings
$-2,187,354,000
Inventory
$122,589,000
Receivables
$227,377,000
ST Investments
$446,324,000
EBIT TTM
$-123,338,000
Pretax Income TTM
$-155,463,000
Interest Exp TTM
$32,125,000
Analysts
18
Yahoo Snapshot (yfinance, live)
Total Revenue
$1,427,939,968
EBITDA
$-151,100,992
Free Cash Flow
$-112,432,000
Enterprise Value
$8,676,480,000
Total Cash
$960,966,016
Total Debt
$354,216,992
Shares Out
23,229,561
Trailing EPS
$-5.85
Book Value
$27.00
ROE
-24.8%
ROA
-6.8%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 958,403,000 | -300,097,000 | -288,284,000 | 1,259,589,000 | 656,900,000 | 602,689,000 | -189,553,000 |
| Dec 2024 | 180,133,000 | -497,875,000 | -465,892,000 | 1,042,247,000 | 287,864,000 | 754,383,000 | -455,572,000 |
| Dec 2023 | 0 | -380,496,000 | -373,630,000 | 640,547,000 | 235,214,000 | 405,333,000 | -324,230,000 |
| Dec 2022 | 0 | -293,571,000 | -295,350,000 | 362,572,000 | 165,183,000 | 197,389,000 | -224,857,000 |
TTM Snapshot
Revenues TTM
$1,283,940,000
NetIncome TTM
$-325,095,000
OpCashFlow TTM
—
Assets (Latest)
$1,244,645,000
Forward EPS
$11.21
Max Pain — expiry 2026-12-18
max pain strike: $500.00 · spot: $398.08 · call oi: 3,295 · put oi: 1,807
Expected Move to 2026-12-18:
±$49.55
(12.45%) —
implied range
$348.53 –
$447.63
· ATM straddle on $400.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| TGTX | TG THERAPEUTICS, INC. | $9.48B | $62.71 | — |
| SYRE | Spyre Therapeutics, Inc. | $8.91B | $93.81 | — |
| SMMT | Summit Therapeutics Inc. | $8.53B | $10.67 | — |
| PRAX | Praxis Precision Medicines, Inc. | $8.53B | $305.06 | — |
| BMRN | BIOMARIN PHARMACEUTICAL INC | $11.33B | $58.51 | — |
News headlines (Yahoo Finance, 1h cache)
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
2026-11-18 21:04 · Yahoo
Madrigal Pharmaceuticals Announces Participation at Three Upcoming Investor Conferences
2026-11-13 13:00 · Yahoo
The Zacks Analyst Blog Highlights TG Therapeutics, BioCryst, Insmed and Madrigal
2026-11-11 06:36 · Yahoo
Madrigal’s MASH Drug Shows Improvements In Liver Health Across 4 Studies, Days After Company Disclosed $1.1B Rezdiffra Sales
2026-11-05 17:25 · Yahoo
Madrigal Announces New Real-World Data at AASLD 2026 Demonstrating Improvements in Liver Stiffness and Cardiometabolic Health Markers with Rezdiffra
2026-11-05 15:00 · Yahoo
First Profitable Quarter Might Change The Case For Investing In Madrigal Pharmaceuticals (MDGL)
2026-11-04 23:17 · Yahoo
Madrigal Pharmaceuticals (MDGL) Stock May Be Below Fair Value Despite First Profit
2026-11-04 18:11 · Yahoo
Madrigal Pharmaceuticals (MDGL) Turns Profitable, Is The 42% Undervaluation Case Still Convincing?
2026-11-04 03:22 · Yahoo
Madrigal Pharmaceuticals Inc (MDGL) Q3 2026 Earnings Call Highlights: First Profitable Quarter ...
2026-11-03 21:05 · Yahoo
Madrigal (MDGL) Q3 2026 Earnings Call Transcript
2026-11-03 20:38 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.